Sotrovimab | List of Frontiers open access articles

Systematic Review

Published on 30 Jan 2024

Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data

in Viral Immunology

Antonio Russo
Pierantonio Grimaldi
Mariantonietta Pisaturo
Lorenzo Onorato
Nicola Coppola

Frontiers in Immunology

doi 10.3389/fimmu.2024.1295029

3,097 views
2 citations

Brief Research Report

Published on 29 Sep 2022

Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections

in Infectious Diseases: Pathogenesis and Therapy

Stefanie Dichtl
Viktoria Zaderer
Viktoria Kozubowski
Hussam Abd El Halim
Eliott Lafon
Lukas Lanser
Günter Weiss
Cornelia Lass-Flörl
Doris Wilflingseder
Wilfried Posch

Frontiers in Medicine

doi 10.3389/fmed.2022.1005589

3,203 views
8 citations

Perspective

Published on 10 Jan 2022

In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein

in Molecular Innate Immunity

Nabarun Chandra Das
Pritha Chakraborty
Jagadeesh Bayry
Suprabhat Mukherjee

Frontiers in Immunology

doi 10.3389/fimmu.2021.782506

10,666 views
46 citations

Case Report

Published on 25 Jul 2022

Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses

in Multiple Sclerosis and Neuroimmunology

Christina Woopen
Urszula Konofalska
Katja Akgün
Tjalf Ziemssen

Frontiers in Immunology

doi 10.3389/fimmu.2022.897748

3,610 views
9 citations

Original Research

Published on 24 Aug 2022

Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab

in Vaccines and Molecular Therapeutics

Clara Luzia Magnus
Andreas Hiergeist
Philipp Schuster
Anette Rohrhofer
Jan Medenbach
André Gessner
David Peterhoff
Barbara Schmidt

Frontiers in Immunology

doi 10.3389/fimmu.2022.966236

5,948 views
25 citations

Original Research

Published on 24 Jan 2022

Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies

in Viral Immunology

Masaud Shah
Hyun Goo Woo

Frontiers in Immunology

doi 10.3389/fimmu.2021.830527

19,970 views
242 citations

Systematic Review

Published on 28 Feb 2025

Effectiveness of pharmacological treatments for COVID-19 due to SARS-CoV-2: a systematic literature review

in Pharmacology of Infectious Diseases

Carolina Garcia Vidal
Jonathan González
Carlos Lumbreras
Miguel Salavert
Antonio Castro
Darío Rubio-Rodríguez
Carlos Rubio-Terrés

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1469681

4,340 views
1 citation

Original Research

Published on 09 May 2024

Characterizing health-related quality of life and identifying disease predictors among patients suspected of having long COVID: an analysis of COMET-ICE clinical trial data

in Infectious Diseases: Epidemiology and Prevention

Heather L. Gelhorn
Parima Ghafoori
Katelyn Cutts
Helen Birch
Yulia Savva
Sacha Satram
Emily Lloyd
Wen-Hung Chen

Frontiers in Public Health

doi 10.3389/fpubh.2024.1278106

3,151 views
1 citation

Articles

Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data

Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections

In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein

Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses

Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab

Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies

Effectiveness of pharmacological treatments for COVID-19 due to SARS-CoV-2: a systematic literature review

Characterizing health-related quality of life and identifying disease predictors among patients suspected of having long COVID: an analysis of COMET-ICE clinical trial data